In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Self-care management intervention in heart failure

Session Poster Session 4

Speaker Sofia Gerward

Event : Heart Failure 2019

  • Topic : heart failure
  • Sub-topic : Chronic Heart Failure: Multidisciplinary Interventions
  • Session type : Poster Session

Authors : SG Sofia Gerward (Lund,SE), DS Daniel Sahlin (Lund,SE)

Authors:
SG Sofia Gerward1 , DS Daniel Sahlin1 , 1Skane University Hospital - Lund - Sweden ,

Citation:

Background

In elderly heart failure (HF) patients there is little experience regarding evaluation of digital self-care management interventions. Previous digital interventions studies in HF has a mean age of 62-65 years.

Purpose

Evaluate a novel home-based self-care intervention in an elderly HF population.

Methods

HF patients were enrolled at five general practitioners and two hospitals and randomized 1:1 to intervention (IG) or control group (CG). The intervention group received a tablet computer with education and symptom monitoring, wirelessly connected to a weight scale and incorporating a titration module for loop-diuretics. Baseline data was collected at randomization and the number of days lost to HF-hospitalizations was analysed using negative binomial regression. Patients will be followed up after eight months, and this is an interim analysis of data after three months.

Results

One hundred patients were randomized to IG, n=50 and CG, n=50. The groups were well balanced at randomization, except for a higher diastolic blood pressure in the CG. The mean age was 79±9, 59 % were male. Five percent were NYHA-class I, 64 % NYHA-class II and 31 % NYHA-class III. There were no significant differences in terms of pharmacological treatment, self-care behaviour or quality of life. A total of 88 HF-related in-hospital days were registered (61 days in the CG group and 27 in the IG). The unadjusted risk ratio between IG and CG was 0.44 (CI: 0.24-0.81) for HF-related in-hospital days. The log rank test for time to event was significant with p-value 0.046. There was no group difference in number of admissions.

Conclusions

This interim analysis indicates a significant reduction of in-hospital days due to HF by 56 % in this elderly HF population.

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are